History of medical mycology in the United States

Clinical Microbiology Reviews

Volumn 9, Issue 2, 1996, Pages 235-272

  Espinel Ingroff, Ana ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BENZIMIDAZOLE; CYCLOHEXIMIDE; ENDOTOXIN; PROPAMIDINE;

BLASTOMYCOSIS; CANDIDIASIS; CHROMOMYCOSIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; DERMATOMYCOSIS; FUNGAL MENINGITIS; HISTOPLASMOSIS; HISTORY OF MEDICINE; HUMAN; LABORATORY DIAGNOSIS; MUCORMYCOSIS; MYCETOMA; MYCOLOGY; OCCUPATIONAL DISEASE; REVIEW; SKIN TEST; SPOROTRICHOSIS; TAXONOMY; TRAINING; UNITED STATES;

EID: 0029911748     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.9.2.235     Document Type: Review

References (479)

1. Ainsworth, G. C. 1986. Introduction to the history of medical and veterinary mycology Cambridge University Press, Cambridge.
2. Ajello, L., and L. D. Zeidberg. 1951. Isolation of Histoplasma capsulatum and Allescheria boydii from soil. Science 113:662-663.
3. Ajello, L., and L. K. Georg. 1957 In vitro hair cultures for differentiating between atypical isolates of T. mentagrophytes and T rubrum. Mycopathologia 8:3-17.
4. Ajello, L., and S.-L. Cheng. 1967. The perfect state of Jnchophylon mentagrophytes. Sabouraudia 5:230-234.
5. Ajello, L. 1968. Chronological record of the Medical Mycological Society of the Americas' Genesis. Bull Med. Mycol. Soc. Am 5:1-2
6. Ajello, L. 1969. Establishment of the Rhoda Benham award. Bull. Med Mycol. Soc. Am 8:1-2.
7. Ajello, L., L. K. Georg, R. T. Steigbigel, and C. J. K. Wang. 1974. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia 66:490-498.
8. Ajello, L. 1981. Lucille K Georg-Pickard - obituary Bull. Med. Mycol. Soc Am. 37:3-4
9. Ajello, L. (Centers for Disease Control, Atlanta). 1994. Personal communication.
10. American Society for Microbiology. 1973. Divisional voting recap. ASM Archives Collection. University of Maryland, Baltimore
11. Aronson, J. D., R. M. Saylor, and E. I. Parr. 1942. Relationship of coccidioidomycosis to calcified pulmonary nodules. Arch. Pathol. 34:31-48.
12. Artz, R. P., and W. E. Bullock. 1979. Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effector responses by activation of splenic suppressor cells Infect. Immun. 23:893-902.
13. Bacon, W. S. 1976 Elizabeth Lee Hazen 1885-1975. Mycologia 68:961-969.
14. Baker, R. D. 1947. Tissue changes in fungus disease. Arch. Pathol. 44:459-466.
15. Bauer, H., J. F. Flanagan, and W. H. Sheldon. 1955 Experimental cerebral mucormycosis in rabbits with alloxan diabetes. Yale J Biol. Med 28:29-36
16. Bauer, H., L. Ajello, E. Adams, and D. U. Hernandez. 1955. Cerebral mucormycosis: pathogenesis of the disease. Am. J. Med. 18:822-831.
17. Beaman, L., D. Pappagianis, and E. Benjamini. 1977. Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect. Immun. 17:580-585.
18. Beaman, L., E. Benjamini, and D. Pappagianis. 1983. Activation of macrophages by lymphokines: enhancement of phagosome-lysosome fusion and killing of Coccidioides immitis. Infect. Immun. 39:1201-1207.
19. Beneke, E. S., R. W. Wilson, and A. L. Rogers. 1969. Extracellular enzymes of Blastomyces dermatitidis. Mycopathologia 39:325-328.
20. Benham, R. W. 1931. Certain momlias parasitic on man: their identification by morphology and by agglutination. J. Infect Dis. 49:183-215
21. Benham, R. W. 1934. The fungi of blastomycosis and coccidioidal granuloma. Arch. Dermatol. Syphilol. 30:385-400.
22. Benham, R. W. 1935. Cryptococci - their identification by morphology and by serology. J Infect Dis. 57:255-274.
23. Benham, R. W. 1939. The cultural characteristics of Pityrosporum ovale - a lipophylic fungus. J. Invest. Dermatol. 2:187-202
24. Benham, R. W., and L. K. Georg. 1948. Allescheria boydii, causative agent in a case of meningitis. J. Invest. Dermatol 10:99-110.
25. Benham, R. W. 1950. Cryptococcosis and blastomycosis Ann N. Y. Acad. Sci. 50:1299-1314.
26. Benham, R. W. 1953. Nutritional studies of the dermatophytes - effect on growth and morphology, with special reference to the production of macroconidia. Trans. N.Y. Acad. Sci. Ser 2 15:102-106.
27. Bennett, J. E., W. E. Dismukes, R. J. Duma, G. Medoff, M. A. Sande, H. Gallis, J. Leonard, B. T. Fields, M. Bradshaw, H. Haywood, Z. A. McGee, T. R. Cate, C. G. Cobbs, J. F. Warner, and D. W. Alling. 1979. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N. Engl. J. Med. 301:126-131.
28. Bennett, J. (National Institutes of Health). 1994 Personal communication.
29. Berliner, M. D., and M. E. Reca. 1970. Release of protoplasts in the yeast phase of Histoplasma capsulatum without added enzyme. Science 167:1255-1257.
30. Bernard, E. M., B. Wong, and D. Armstrong. 1985 Steroisomeric configuration of arabinitol in serum, urine, and tissues in invasive candidiasis. J. Infect. Dis. 151:711-715.
31. Bille, J., L. Stockman, G. D. Roberts, C. D. Horstmeier, and D. M. Ilstrup. 1983. Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood J. Clin. Microbiol. 18:469-471
32. Binford, C. H., R. K. Thompson, M. E. Gorham, and C. W. Emmons. 1952. Mycotic brain abscess due to Cladosporium trichoides, a new species. Am. J. Clin. Pathol. 22:535-542
33. Blanchard, D. K., M. B. Michelini-Norris, and J. Y. Djeu. 1991. Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function Blood 79:2259-2265.
34. Block, E. R., A. E. Jennings, and J. E. Bennett. 1973 5-Fluorocytosine resistance in Cryptococcus neoformans Antimicrob. Agents Chemother. 3:647-656.
35. Bloomfield, N., M. A. Gordon, and D. F. Elmendorf. 1963. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutina-tion. Proc. Soc. Exp. Biol Med 114:64-67.
36. Bodey, G. P. 1966 Fungal infections complicating acute leukemia. J. Chronic Dis. 19:667-687
37. Bowman, W. B. 1919. Coccidioidal granuloma. Am. J. Roentgenol. 6:547-555
38. Boyd, M. F., and E. D. Crutchfield. 1921. A contribution to the study of mycetoma in North America. Am. J. Trop. Med. 1:215-289
39. Bozzette, S. A., R. A. Larsen, J. Chiu, M. A. Leal, J. Jacobsen, and the California Collaborative Treatment Group. 1991. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:580-584.
40. Brummer, E., and D. A. Stevens. 1984. Activation of murine polymorphonuclear neutrophils for fungicidal activity with supernatants from antigen-stimulated immune spleen cell cultures. Infect. Immun 45:447-542
41. Brummer, E., N. Kurita, S. Yoshida, K. Nishimura, and M. Miyaji. 1992. A basis for resistance of Blastomyces derinatitis killing by human neutrophils: inefficient generation of myeloperoxidase system products. J. Med. Vet. Mycol. 30:233-243
42. Brummer, E., P. R. Bhagavathula, L. H. Hanson. and D. A. Stevens. 1992. Synergy of itraconazole with macrophage in killing Blastomyces dermutitidis Antimicrob. Agents Chemother. 35:2487-2492.
43. Brummer, E., L. H. Hanson, and D. A. Stevens. 1993. IL-4, IgE, and interferon-production in pulmonary blastomycosis, comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304). Cell Immunol. 149:258-267.
44. Buchman, T. G., M. Rossier, W. G. Merz, and P. Charache. 1990. Detection of surgical pathogens by in vitro DNA amplification. I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery 108:338-347.
45. Bulmer, G. S., M. D. Sans, and C. M. Gunn. 1967. Cryptococcus neoformans. I. Nonencapsulated mutants J. Bacteriol. 94:1475-1479.
46. Bulmer, G. S., and M. D. Sans. 1967. Ctyptococcus neoformans. II. Phagocytosis by human leukocytes. J. Bacteriol. 94:1480-1483.
47. Burke, R. C. 1961. Tinea versicolor: susceptibility factors and experimental infection in human beings. J. Invest Dermatol. 36:389-402.
48. Burnie, J. P., and J. D. Williams. 1985. Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis. Eur J. Clin Microbiol. 4:98-101.
49. Busey, J. F., R. Baker, L. Birch, H. Buechner, E. W. Chick, F. K. Justice, J. H. Matthews, S. McDearman, D. N. Pickar, W. D. Sutliff, H. E. Walkup, and S. Zimmerman. 1964. Blastomycosis. I. A review of 198 collected cases in Veterans Administration Hospitals. Am. Rev. Respir. Dis. 89:659-672.
50. Calderone, R. A., L. Linehan, E. Wadsworth, and A. L. Sandberg. 1988 Identification of C3d receptors on Candida albicans. Infect Immun. 56: 252-258.
51. Campbell, C. C. 1947. Reverting Histoplasma capsulatum to the yeast phase. J Bacteriol 54:263-264.
52. Campbell, C. 1983. Chester Wilson Emmons - dean of U.S. medical mycologists. Unpublished manuscript Medical Mycological Society of the Americas Archives, Division of Infectious Diseases, Virginia Commonwealth University/MCV, Richmond.
53. Campbell, C. 1984. Norman Francis Conant - the beloved instructor. Unpublished manuscript. Medical Mycological Society of the Americas Archives. Division of Infectious Diseases, Virginia Commonwealth University/ MCV, Richmond
54. Caplan, L. M., and W. G. Merz. 1978 Evaluation of two commercially prepared biphasic media for recovery of fungi from blood J. Clin. Microbiol. 8:469-470
55. Carle, C. F., and M. V. Olson. 1984. Separation of chromosomal DNA molecules from yeasts by orthogonal-field alternation gel electrophoresis. Nucleic Acids Res 12:5647-5664.
56. Carle, G. F., M. Frank, and M. V. Olson. 1986. Electrophoretic separations of large DNA molecules by periodic inversion of the electric field. Science 232:65-68.
57. Caroline, L., F. Rosner, and P. J. Kozinn. 1969. Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia. Blood 34:441-451.
58. Chezzi, C. 1992. Editorial. Dr Libero Ajello. Eur. J. Epidemiol. 8:319-320.
59. Chick, E. W., J. Evans, and R. R. Baker. 1958. The inhibitory effect of amphotericin B on localized Rhizopus oryzae infection (mucormycosis) utilizing the pneumoderma pouch of the rat. Antibiot. Chemother. 8:506-510
60. Christie, A., and J. C. Peterson. 1945. Pulmonary calcification in negative reactors to tuberculin Am. J. Public Health 35:1131-1147.
61. Chu, G., D. Vollrath, and R. W. Davis. 1986. Separation of large DNA molccules by contour-clamped homogeneous electric fields. Science 234: 1582-1585.
62. Clemons, K. (Santa Clara Medical Center at San Jose). 1994. Personal communication.
63. Cole, G. T., K. Saha, K. R. Seshan, K. T. Lynn, M. Franco, and P. K. Y. Wong. 1992. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis. Infect Immun. 60:4168-4178.
64. Cole, G. T., S. Zhu, L. Hsu, D. Kruse, K. R. Seshan, and F. Wang. 1992 Isolation and expression of a gene which encodes a wall-associated proteinase of Coccidioides immitis. Infect. Immun. 60:416-427.
65. Conant, N. F. 1969. A bit of history (third annual MMSA lecture). Bull Med Mycol. Soc. Am 7:1-4.
66. Converse, J. L. 1957 Effect of surface-active agents on endosporulation of Coccidioides immitis in a chemically defined medium. J. Bacteriol. 74:106-107.
67. Cooke, J. V. 1915. Immunity tests in coccidioidal granuloma. Arch Intern Med. 15:479-486.
68. Coons, A., and M. H. Kaplan. 1950. Localization of antigen in tissue cells. II. Improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp. Med. 91:1-13.
69. Cooper, C. R., and P. J. Szaniszlo. 1993 Evidence for two cell division cycle (CDC) genes that govern bud emergence in the pathogenic fungus Wangiella dermatitidis. Infect. Immun. 61:2069-2081.
70. Cox, R. A., and L. A. Britt. 1987. Antigenic identity of biologically active antigen in coccidioidin and spherulin. Infect. Immun. 55:2590-2596.
71. Creitz, J., and H. W. Harris. 1955. Isolation of Allescheria boydii from sputum. Am. Rev. Tuberculosis 71:126-130.
72. Currie, B. P., L. F. Freundlich, and A. Casadevall. 1994. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J. Clin. Microbiol. 32:1188-1192.
73. Cutler, J. E., P. M. Glee, and H. L. Horn. 1988. Candida albicans and Candida stellatoidea - specific DNA fragment. J. Clin. Microbiol. 26:1720-1724.
74. Darling, S. T. 1906. A protozoon general infection producing pseudotubercles in the lungs and focal necroses in the liver, spleen and lymphnodes. J. Am. Med. Assoc. 46:1283-1285.
75. da Rocha-Lima, H. 1912-1913. Beitrag zur kenntnis der Blastomykoses Lymphangitis epizootica und Histoplasmosia. Zentralbl Bakteriol. 67:233-249.
76. Davidson, A. M., and P. H. Gregory. 1934. In situ cultures of dermatophytes Can J. Res. 10:373-393
77. Davis, D. J. 1913. The morphology of Sporothrix schenckii in tissues and in artificial media. J. Infect Dis. 12:453-458.
78. Deepe, G. S. 1988. Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells. Infect. Immun 56:2350-2355.
79. de Hoog, G. S., E. Guého, F. Masclaux, A. H. G. Gerrits van den Ende, K. J. Kwon-Chung, and M. R. McGinnis. 1995. Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J. Med Vet Mycol. 33:339-347.
80. DeMonbreun, W. A. 1934 The cultivation and culturation characteristics of Darling's Histoplasma capsulatium. Am. J. Trop. Med. 14:93-125.
81. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1989. Treatment of invasive aspergillosis with rtraconazole Am. J. Med. 86:791-800.
82. Denning, D. W., R. M. Tucker, L. H. Hanson, J. R. Hamilton, and D. A. Stevens. 1989. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch. Intern Med 149:2301-2308.
83. Denning, D. W., J. Y. Lee, J. S. Hostetler, P. Pappas, C. A. Kauffman, D. H. Dewsnup, J. N. Galgiani, J. R. Graybill, A. M. Sugar, A. Catanzaro, H. Gallis, J. R. Perfect, B. Dockery, W. E. Dismukes, and D. A. Stevens. 1994. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive aspergillosis. Am. J. Med 97:135-144.
84. Denton, J. F., E. S. McDonough, L. Ajello, and R. J. Ausherman. 1961. Isolation of Blastomyces dermatitidis from soil. Science 133:1126-1127
85. deRepentigny, L., L. D. Marr, J. W. Keller, A. W. Carter, R. J. Kuykendall, L. Kaufman, and E. Reiss. 1985. Comparison of enzyme immunoassay and gas-liquid chromotography for the rapid diagnosis of invasive candidiasis in cancer patients. J. Clin. Microbiol. 21:972-979.
86. Diamond, R. D., and J. E. Bennett. 1974. Prognostic factors in cryptococcal meningitis: a study of 111 cases. Ann. Intern. Med. 80:176-180.
87. Diamond, R. D., and A. C. Allison. 1976. Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect. Immun. 14:716-720.
88. Diamond, R. D. 1977. Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis. Infect. Immun. 17:187-194.
89. Diamond, R. D., and R. Krzesicki. 1978. Mechanisms of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro. J. Clin. Invest. 61:360-369.
90. Diamond, R. D., R. Krzesicki, B. Epstein, and J. Willington. 1978. A possible host defense mechanism in aspergillosis and mucormycosis. Am. J. Pathol. 91:313-323.
91. Dickson, E. C. 1915. Oidiomycosis in California, with especial reference to coccidioidal granuloma. Arch. Intern. Med. 16:1028-1044.
92. Dickson, E. C. 1937. "Valley Fever" of the San Joaquin Valley and fungus coccidioides. Calif. Western Med. 47:151-155.
93. Dickson, E. C. 1937. Coccidioides infection I. Arch. Intern. Med. 57:1029-1044.
94. Dickson, E. C., and M. A. Gifford. 1938. Coccidioides infection (coccidioidomycosis). II. The primary type of infection. Arch. Intern. Med. 62:853-871.
95. DiSalvo, A. (Nevada State Health Laboratory). 1994. Personal communication.
96. Dismukes, W. E., G. Cloud, H. A. Gallis, T. M. Kerkering, G. Medoff, and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. 1987. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N. Engl. J. Med 317:334-341.
97. Dismukes, W. E., R. W. Bradsher, G. C. Cloud, C. A. Kauffman, S. W. Chapman, R. B. George, D. A. Stevens, W. M. Girard, M. S. Saag, C. Bowles-Patton, and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. 1992. Itraconazole therapy for blastomycosis and histoplasmosis. Am. J. Med 93:489-497.
98. Dismukes, W. (University of Alabama at Birmingham). 1994. Personal communication.
99. Djeu, J. Y., D. K. Blanchard, D. Halkias, and H. Friedman. 1986. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon and tumor necrosis factor. J Immunol. 137:2980-2984.
100. Dodd, K., and E. H. Tompkins. 1934. A case of histoplasmosis of Darling in an infant. Am. J. Trop. Med. 14:127-137.
101. Domer, J. E. 1971. Monosaccharide and chitin content of cell walls of Histoplasma capsulatum and Blastomyces dermatitidis. J. Bacteriol. 207:870-877.
102. Domer, J. E., R. E. Garner, and R. N. Befidi-Mengue. 1989. Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect. Immun. 57:693-700
103. Domer, J. E. (Tulane University at New Orleans). 1994. Personal communication.
104. Dong, Z. M., and J. W. Murphy. 1993. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect. Immun. 61:5067-5077.
105. Dorn, G. L., G. A. Land, and G. E. Wilson. 1979. Improved blood culture technique based on centrifugation: clinical evaluation. J. Clin. Microbiol. 9:391-396.
106. Drutz, D. J., A. Spickard, D. E. Rogers, and M. G. Koenig. 1968. Treatment of disseminated mycotic infections, a new approach to amphotericin B therapy. Am. J Med 45:405-418.
107. Drutz, D., and C. L. Frey. 1985. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts J Lab. Clin. Med. 105:737.
108. Edman, J. C., and K. J. Kwon-Chung. 1990 Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker foi transformation. Mol. Cell. Biol. 10:4538-4544.
109. Elson, W. O. 1945. The antibacterial and fungistatic properties of propamidine. J. Infect. Dis 76:193-197.
110. Emmons, C. W. 1934. Dermatophytes: natural grouping based on the form of the spores and accessory organs. Arch. Dermatol. Syphilol. (Chicago) 30:337-362.
111. Emmons, C. W. 1942 Isolation of Coccidioides from soil and rodents. Public Health Rep. (Washington) 57:109-111.
112. Emmons, C. W. 1944 Allescheria boydii and Monosporium apiospermum. Mycologia 36:188-193
113. Emmons, C. W. 1945. Phialophora jeanselmei comb. n. from mycetoma of the hand. Arch. Pathol. 39:364-368.
114. Emmons, C. W. 1949. Isolation of Histoplasma capsulatum from soil. Public Health Rep. (Washington) 64:892-896.
115. Emmons, C. W. 1951. Isolation of Cryptococcus neoformans from soil. J. Bacteriol. 62:685-690.
116. Emmons, C. W. 1955. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia). Am. J. Hyg. 62:227-232.
117. Emmons, C. W. 1968. The elusive fungi (second annual MMSA lecture). Bull. Med. Mycol. Soc. Am. 4:1-3.
118. Ernst, H. C. 1918. A case of mucor infection. J. Med. Res. 39:143-146
119. Espinel-Ingroff, A., C. W. Kish, Jr., T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
120. Espinel-Ingroff, A. 1994. Ph.D thesis. Virginia Commonwealth University, Richmond
121. Evans, E. E. 1949. An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytica). Proc. Soc. Exp. Biol. Med. 71:644-646.
122. Evans, E. E. 1950. The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J. Immunol. 64:423-430.
123. Evans, E. E., and J. F. Kessel. 1951. The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide. J. Immunol. 67:109-114.
124. Evans, E. E., and R. J. Theriault. 1953. The antigenic composition of Cryptococcus neoformans. IV. The use of paper chromatography for following purification of the capsular polysaccharide. J. Bacteriol 65:571-577.
125. Eveland, W. C., J. D. Marshall, A. M. Silverstein, F. B. Johnson, L. Iverson, and D. J. Wilson. 1957. Specific immunochemical staining of Cryptococcus neoformas and its polysaccharide in tissue. Am. J. Pathol. 33:616-617.
126. Fidel, P. L., and J. W. Murphy. 1989. Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation. Infect. Immun. 57:1158-1164.
127. Fiese, M. J. 1957. Treatment of disseminated coccidioidomycosis with amphotericin B: report of a case. Calif Med. 86:119-124.
128. Fineman, B. C. 1921. A study of the thrush parasite. J. Infect. Dis. 28:185-200.
129. Fisher, J. (Medical College of Georgia at Augusta). 1993. Personal communication.
130. Foerster, H. R. 1926 Sporotrichosis, an occupational dermatosis. J. Am. Med. Assoc. 87:1605-1609.
131. Francis, P., J. W. Lee, A. Hoffman, J. Peter, A. Francesconi, J. Bacher, J. Shelhamer, P. A. Pizzo, and T. J. Walsh. 1994. Efficiency of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection J. Infect. Dis. 169:356-368.
132. Freeman, W., and F. D. Weidman. 1923. Cystic blastomycosis of the cerebral gray matter Arch Neurol. Psychiatry 2:589-603.
133. Freeman, W. 1933. Fungus infections of the central nervous system. Ann. Intern Med. 6:595-607
134. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
135. Frothingham, L. 1902. Lesion in the lung of a horse: a tumor-like lesion in the lung of a horse caused by a blastomyces (Torula). J. Med. Res. 8:31-43.
136. Furcolow, M. L. 1963. Comparison of treated and untreated severe histoplasmosis: a Communicable Disease Center Cooperative Mycoses Study. JAMA 183:823-829.
137. Furcolow, M. L., E. W. Chick, J. F. Busey, and R. W. Menges. 1970. Prevalence and incidence studies of human and canine blastomycosis Am. Rev. Respir. Dis. 102:60-67.
138. Galgiani. J. N., R. A. Isenberg, and D. A. Stevens. 1978. Chemotaxigenic activity of extracts, from the mycelial and spherule phases of Coccidioides immitis for human polymorphonuclear leukocytes. Infect. Immun 21:862-865.
139. Galgiani, J. N., A, Catanzaro, G. A. Cloud, J. Higgs, B. A. Friedman, R. A. Larsen, J. R. Graybill, and the National Institute for Allergy and Infectious Diseases Mycoses Study Group. 1993. Fluconazole therapy for coccidioidal meningitis. Ann. Intern. Med 119:28-35
140. Galgiani, J. (VA Medical Center at Tucson). 1993. Personal communication.
141. Gantz, N. M., J. L. Swain, A. A. Medeiros, and T. F. O'Brien. 1974. Vacuum blood-culture bottles inhibiting growth of Candida and fostering growth of Bacteroides. Lancet ii:1174-1176.
142. Gass, R. S., R. L. Gauld, E. F. Harrison, H. C. Stewart, and W. C. Williams. 1938. Tuberculosis studies in Tennessee. Am. Rev. Tuberculosis 38:441-447.
143. Geiger, A. J., H. A. Wenner, H. D. Axilrod, and S. H. Durlacher. 1946. Mycotic endocarditis and meningitis. Yale J Biol. Med. 18:259-268
144. Geis, P. A., M. H. Wheeler, and P. J. Szaniszlo. 1984 Pentaketide metabolites of melanin synthesis in the dematiaceous fungus Wangiella dermatitidis. Arch. Microbiol. 137:324-328.
145. Gentles, J. C. 1958. Experimental ringworm in guinea pigs: oral treatment with griseofulvin. Nature (London) 182:476-477.
146. Gentry, L. O., I. D. Wilkinson, A. S. Lea, and M. F. Price. 1983. Latex agglutination test for detection of Candida antigen in patients with disseminated disease. Eur. J. Clin. Microbiol. 2:122-128.
147. Georg, L. K. 1949. Influence of nutrition on growth and morphology of the dermatophytes. Trans. N.Y. Acad. Sci Ser. 2 11:281-286.
148. Georg, L. K., L. Ajello, and M. A. Gordon. 1951. A selective medium for the isolation of Coccidioides immitis. Science 114:387-389.
149. Georg, L. K., and L. B. Camp. 1957. Routine nutritional tests for the identification of dermatophytes. J. Bacteriol. 74:113-121.
150. Georg, L. K., L. Ajello, L. Friedman, and S. A. Brinkman. 1962 A new species of Microsporum pathogenic to man and animals Sabouraudia 1:189-196
151. Gilchrist, T. C. 1894. Protozoan dermatitidis J. Cutaneous Dis. 12:496
152. Gilchrist, T. C. 1896. A case of blastomycetic dermatitis in man. Johns Hopkins Hosp. Rep. 1:269-283.
153. Gilchrist, T. C., and W. R. Stokes. 1896. The presence of an Oidium in the tissues of a case of pseudo-lupus vulgaris: preliminary report. Bull. Johns Hopkins Hosp. 7:129-133.
154. Gilchrist, T. C. and W. R. Stokes. 1898. A case of pseudo-lupus vulgaris caused by a Blastomyces. J. Exp Med. 3:53-83
155. Gold, W., H. A. Stout, J. F. Pagano, and R. Donovick. 1955-1956. Amphotericin A and B, amtifungal antibiotics produced by a streptomycete. I. In vitro studies of A. Antibiot. Annu. 1955-1956:579-586.
156. Gomori, G. 1946. A new histochemical test for glycogen and mucin. Am. J. Clin. Pathol. 10:177-179
157. Goodman, N. L. 1985. Biography of Michael L. Furcolow. Unpublished manuscript. Medical Mycological Society of the Americas Archives, Division of Infectious Diseases, Virginia Commonwealth University/MCV, Richmond.
158. Goodman, N. (University of Kentucky at Lexington). 1994. Personal communication.
159. Goodman, N. L., and G. D. Roberts. 1994. Howard W. Larsh - 1914-1993 Mycopathologia 125:1-2
160. Gordon, M. A. 1951. The lipophilic mycoflora of the skin. I. In vitro culture of Pityrosporum orbiculare n sp. Mycologia 43:524-535.
161. Gordon, M. A. 1958. Differentiation of yeasts by means of fluorescent antibody Proc. Soc. Exp. Biol. Med. 92:694-698.
162. Gordon, M. A., and E. Lapa. 1964. Serum protein enhancement of antibiotic therapy in cryptococcosis. J. Infect. Dis. 114:373-377
163. Gordon, M. A. 1993. A career in medical mycology. Unpublished manuscript Medical Mycological Society of the Americas Archives, Division of Infectious Diseases, Virginia Commonwealth University/MCV, Richmond.
164. Graybill, J. R, D. A. Stevens, J. N. Galgiani, A. M. Sugar, P. C. Craven, C. Gregg, M. Huppert, G. A. Cloud, and W. E. Dismukes. 1988. Ketoconazole treatment of coccidioidal meningitis. Ann. N.Y Acad. Sci. 544:488-496.
165. Graybill, J. R., D. A. Stevens, J. N. Galgiani, W. E. Dismukes, G. A. Cloud, and the National Institute for Allergy and Infectious Diseases Mycoses Study Group. 1990. Itraconazole treatment of coccidioidomycosis. Am. J. Med. 89:282-290.
166. Gregory, J. E., A. Golden, and W. Haymaker, 1943. Mucormycosis of the central nervous system A report of three cases. Bull. Johns Hopkins Hosp. 73:405-419.
167. Gridley, M. F. 1953. A stain for fungi in tissue reactions. Am. J. Clin. Pathol 23:303-307.
168. Grocott, R. C. 1955. A stain for fungi in tissue and smears using Gomori's methenamine-silver nitrate technique. Am. J. Clin Pathol. 25:975-979.
169. Hageage, G. J., and B. J. Harrington. 1984. Use of calcofluor white in clinical mycology Lab. Med. 15:109-112.
170. Haggerty, T. E., and L. E. Zimmerman. 1958. Mycotic keratitis. Southern Med. J 51:153-159
171. Halde, C. 1993. Personal communication.
172. Haley, L. 1993. Personal communication.
173. Hall, G. S., K. Pratt-Rippin, and J. A. Washington. 1992. Evaluation of a chemiluminescent probe assay for identification of Histoplasma capsulatum isolates. J. Clin. Microbiol. 30:3003-3004.
174. Hamburger, W. W. 1907. A comparative study of four strains of organisms isolated from four cases of generalized blastomycosis. J. Infect. Dis. 4:201-209.
175. Hansmann, G. H., and J. R. Schenken. 1934. A unique infection in man caused by a new yeast-like organism, a pathogenic member of the genus Sepedonium. Am. J. Pathol. 10:731-738.
176. Harrell, E. R., and A. C. Curtis. 1957. The treatment of North American blastomycosis with amphotericin B. Arch. Dermatol. 76:561-569.
177. Hasenclever, H. F., and W. O. Mitchell. 1961 Antigenic studies of Candida J. Bacteriol. 82:578-581.
178. Hazen, E. L. 1947. Microsporum audouinu: the effect of yeast extract, thiamine, pyridoxine, and Bacillus weidmaniensis on the colony characteristics and macroconidial formation. Mycologia 39:200-209.
179. Hazen, E. L., and R. Brown. 1950. Two antifungal agents produced by a soil actinomycete Science 112:423
180. Heiner, D. C. 1958. Diagnosis of histoplasmosis using precipitin reactions in agar gel. Pediatrics 22:616-627.
181. Hektoen, L., and C. F. Perkins. 1900-1901. Refractory subcutaneous abscesses caused by Sporothrix schenokii, a new pathogenic fungus. J. Exp. Med 5:77-89
182. Henrici, A. T. 1939. An endotoxin from Aspergillus fumigatus. J. Immunol 36:319-338.
183. Hidore, M. R., N. Nabavi, F. Sonleitner, and J. W. Murphy. 1991 Murine natural killer cells are fungicidal to Cryptococcus neoformans Infect. Immun. 59:1747-1754.
184. Hirsch, E. F., and H. Benson. 1927. Specific skin and testis reactions with culture filtrates of Coccidioides immitis. J. Infect Dis. 40:629-633.
185. Hodges, R. S. 1928. Cultures of ringworm fungi on Sabouraud's proof mediums and on mediums prepared with American peptones and sugars. Arch. Dermatol. Syphilol. 18:852-856.
186. Hopfer, R. L., and D. Groschel. 1975 Six-hour pigmentation test for the identification of Cryptococcus neoformans. J. Clin. Microbiol. 2:96-98.
187. Hopfer, R. L., K. Mills, and D. Groschel. 1979 Improved blood culture medium for radiometric detection of yeasts. J. Clin. Microbiol. 9:448-449.
188. Hopfer, R. L., P. Walden, S. Setterquist, and W. E. Highsmith. 1993. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J. Med. Vet. Mycol. 31:65-75.
189. Hotchkiss, R. D. 1948 A microchemical reaction resulting in the staining of the polysaccharide structures in fixed tissue preparations. Arch. Biochem. 16:131-141.
190. Howard, D. H. 1961. Dimorphism in Sporotrichum schenckii J. Bacteriol. 81:464-469
191. Howard, D. H, 1965. Intracellular growth of Histoplasma capsulatum J. Bacteriol. 89:518-523.
192. Howard, D. H. 1974. In appreciation. Bull. Med Mycol. Soc Am. 23:4-5.
193. Howard, D. H., and V. Otto. 1977. Experiments on lymphocyte-mediated cellular immunity in murine histoplasmosis. Infect. Immun. 16:226-231.
194. Hube, B., C. J. Turner, F. C. Odds, H. Eiffert, G. J. Boulnois, H. Kochel, and R. Ruchel. 1991. Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J. Med. Vet. Mycol. 22:129-132.
195. Huppert, M., and E. L. Keeney. 1959. Immunization against superficial fungous infection. J. Dermatol 52:15-19.
196. Huppert, M., and J. W. Bailey. 1965. The use of immunodiffusion test which correlates with complement fixation. J. Clin. Pathol 44:364-368.
197. Huppert, M., E. T. Peterson, S. H. Sun, P. A. Chitjian, and W. J. Derrevere. 1968. Evaluation of a latex particle agglutination test for coccidioidomycosis. Am. J. Clin Pathol. 49:96-102.
198. Huppert, M., D. J. Oliver, and S. H. Sun. 1978. Combined methenamine silver nitrate and hematoxylin and eosin stain for fungi in tissues. J. Clin. Microbiol 8:598-603.
199. Hutter, R. V. P., P. H. Lieberman, and H. S. Collins. 1964 Aspergillosis in a cancer hospital. Cancer 17:747-756.
200. Jacobson, E. S., D. J. Ayers, A. C. Harrell, and C. C. Nicholas. 1982 Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans J. Bacteriol. 150:1292-1296.
201. Jacobson, E. S., and H. S. Emery. 1991. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J. Bacteriol. 173:401-403.
202. Jacobson, E. S., and S. B. Tinnell. 1993. Antioxidant function of fungal melanin. J. Bacteriol. 175:7102-7104
203. Joachim, H., and S. H. Polayes. 1940. Subacute endocarditis and systemic mycosis (Momlia) JAMA 115:205-208
204. Johnson, S. M., C. R. Zimmermann, and D. Pappagianis. 1993. Aminoterminal sequence analysis of the Coccidioides immitis chitinase/immunodiffusion-complement fixation protein Infect Immun. 61:3090-3092.
205. Kanbe, T., R.-K. Li, E. Wadsworth, R. A. Calderone, and J. E. Cutler. 1991. Evidence for expression of the C3d receptor of Candida albicans in vitro and in vivo obtained by immunofluorescence and immunoelectron microscopy. Infect. Immun. 59:1832-1838.
206. Kaplan, W., and M. S. Ivens. 1960. Fluorescent antibody staining of Sporotrichum schenckii in cultures and clinical materials. J Invest. Dermatol. 35:151-159.
207. Kaplan, W., and D. E. Kraft. 1969. Demonstration of pathogenic fungi in formalin-fixed tissues by immunofluorescence. Am. J. Clin. Pathol. 52:420-432.
208. Kaplan, W. (Centers for Disease Control, Atlanta, Ga.). 1994 Personal communication.
209. Kauffman, C. A., K. S. Israel, J. W. Smith, A. C. White, J. Schwarz, and G. F. Brooks. 1978. Histoplasmosis in immunosuppressed patients. Am J Med. 64:923-932.
210. Kaufmann, C. S., and W. G. Merz. 1989. Electrophoretic karyotypes of Torulopsis glabiata J Clin. Microbiol. 27:2165-2168
211. Kaufman, L., and W. Kaplan. 1961 Preparation of a fluorescent antibody specific for the yeast phase of Histoplasma capsulatum. J. Bacteriol. 82:729-735.
212. Keath, E. J., E. D. Spitzer, A. A. Painter, S. J. Travis, G. S. Kobayashi, and G. Medoff. 1989. DNA probe for the identification of Histoplasma capsulatum. J. Clin. Microbiol. 27:2369-2372.
213. Keddie, F., and S. Shadomy. 1963 Etiological significance of Pityrosporum orbiculare in tinea versicolor. Sabouraudia 3:21-25.
214. Kerkering, T. M., R. J. Duma, and S. Shadomy. 1981. The evolution of pulmonary cryptococcosis Ann Intern. Med 94:611-616.
215. Kessler, G., and W. J. Nickerson. 1959. Glucomannan-protein complexes from cell walls of yeasts J. Biol. Chem. 234:2281-2285.
216. Keye, J. D., Jr., and W. E. Magee. 1956. Fungal diseases in a general hospital. Am. J. Clin. Pathol. 26:1235-1253
217. Khakpour, F. R., and J. W. Murphy. 1987. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Infect. Immun. 55:1657-1662
218. Kiehn, T. E., E. M. Bernard. J. W. M. Gold, and D. Armstrong. 1979.
219. Kiessling, R., E. Klein, and H. Wigzell. 1975. "Natural" killer cells in the mouse I Cytotoxic cells with specificity for mouse Moloney leukemia cells: specificity and distribution according to genotype. Eur. J. Immunol. 5:112.
220. Kirkland, T. N., S. Zhu, D. Kruse, L. Hsu, K. R. Seshan, and G. T. Cole. 1991. Coccidioides immitis fractions which are antigenic for immune T lymphocytes Infect Immun. 59:3952-3961.
221. Klein, R. S., C. A. Harris, C. B. Small, B. Moll. M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358.
222. Kligman, A. M., H. Mescon, and E. D. DeLamater. 1951 The Hotchkiss-McManus stain for the histopathologic diagnosis of fungus diseases. Am. J. Clin. Pathol. 21:86-91.
223. Kligman, A. M. 1952. The pathogenesis of tinea capitis due to Microsporum audouini and Microsporum canis. I. Gross observations following the inoculation of humans. J. Invest. Dermatol. 18:231-246.
224. Kligman, A. M. 1955 Tinea capitis due to M. audouini and M. canis. II. Dynamics of the host-parasite relationship. Arch. Dermatol. Syphilol 71: 313-337.
225. Kobayashi, G. 1982. Summary of training proposal. Washington University, St. Louis, Mo.
226. Kobayashi, G. (Washington University). 1994 Personal communication
227. Komorowski, R. A., and S. G. Farmer. 1973 Rapid detection of candidemia. Am J. Clin. Pathol. 59:56-61
228. Kozel, T. R., and T. G. McGaw. 1979. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages. Infect Immun. 25:255-261.
229. Kozel, T. R., M. A. Wilson, G. S. T. Pfrommer, and A. M. Schlageter. 1989 Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reinstituted from six isolated proteins. Infect. Immun. 57:1922-1927.
230. Kruse, D., and G. T. Cole. 1992. A seroreactive 120-kilodalton β-1,3-glucanase of Coccidioides immitis which may participate in spherule morphogenesis. Infect. Immun. 60:4350-4363.
231. Kumar, V., B. Maresca, M. Sacco, R. Goewert, G. Kobayashi, and G. Medoff. 1983. Purification and characterization of a cysteine dioxygenase from the yeast phase of Histoplasma capsulatum. Biochemistry 22:762-768.
232. Kurtz, M. B., M. W. Cortelyou, and D. R. Kirsch. 1986. Integrate transformation of Candida albicans, using a cloned Candida ADE2 gene. Mol. Cell. Biol. 6:142-149.
233. Kwon, K. J., D. I. Fennell, and K. B. Raper. 1964. A heterothallic species of Aspergillus Am. J. Bacteriol. 51:679
234. Kwon-Chung, K. J. 1972. Emmonstella capsulata: perfect stage of Histoplasma capsulatum Science 177:368-369.
235. Kwon-Chung, K. J. 1975. Perfect state (Emmonstella capstilata) of the fungus causing large-form African histoplasmosis Mycologia 47:980-990.
236. Kwon-Chung, K. J. 1975 Filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 57:1197-1200.
237. Kwon-Chung, K. J., D. Lehman, C. Good, and P. T. Magee. 1985. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans Infect. Immun. 49:571-575.
238. Kwon-Chung, K. J., and C. C. Campbell. 1986. Chester Wilson Emmons. J. Med. Vet. Mycol. 24:89-90.
239. Kwon-Chung, K. J., J. C. Edman, and B. L. Wickes. 1992. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect. Immun. 60:602-605.
240. Kwon-Chung, K. J. (National Institutes of Health). 1994. Personal communication.
241. Land, G. A., E. C. Vinton, G. B. Adcock, and J. M. Hopkins. 1975 Improved auxanographic method for yeast assimilations: a comparison with other approaches. J. Clin Microbiol. 2:206-227.
242. Land, G. A., W. C. McDonald, R. L. Stjernholm, and L. Friedman. 1975. Factors affecting filamentation in Candida albicans: changes in respiratory activity of C albicans during filamentation. Infect. Immun. 12:119-127.
243. Land, G. A., B. A. Harrison, K. L. Hulme, B. H. Cooper, and J. C. Byrd. 1979 Evaluation of the new API 20C strep for yeast identification against conventional method J Clin. Microbiol. 3:357-364.
244. Lane, C. G. 1915. A cutaneous lesion caused by a new fungus (Phialophora verrucosa). J Cutaneous Dis 33:840-846.
245. Leach, B. E., J. H. Ford, and A. J. Whiffen. 1947. Actidione. an antibiotic from Streptomyces griseus. J. Am. Chem. Soc. 69:474.
246. Lehmann, P. F., and E. Reiss. 1978. Invasive aspergillosis: antiserum for circulating antigen produced after immunization with serum from infected rabbits. Infect Immun. 20:570-572.
247. Lehmann, P. F., D. Lin, and B. A. Lasker. 1992 Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J Clin. Microbiol. 30:3249-3254.
248. Lehrer, R. I., and M. J. Cline. 1969. Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. 98:996-1004.
249. Lehrer, R. I., T. Ganz, D. Szklarek, and M. E. Selsted. 1988. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J. Clin. Invest. 81:1829-1835.
250. Levine, H. B., A. González-Ochoa, and D. R. Ten Eyck. 1973. Dermal sensitivity to Coccidioudes immitis: a comparison of responses elicited in man by spherulin and coccidioidin. Am. Rev. Respir. Dis. 107:379-386.
251. Levine, H. (Naval Biological Laboratories). 1994. Personal communication.
252. Levitz, S. M., and R. D. Diamond. 1985. Mechanisms of resistance of Aspergillus fumigatus condidia to killing by neutrophils in vitro. J. Infect. Dis. 152:33-42.
253. Levitz, S. M., M. E. Selsted, T. Ganz, R. I. Lehrer, and R. D. Diamond. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect Dis. 154:483-489.
254. Lim, T. S., J. W. Murphy, and L. K. Cauley. 1980. Host-etiological agent interactions in intranasally and introperitoneally induced cryptococcosis in mice. Infect. Immun. 29:633-641.
255. Littman, M. L., and P. L. Horowitz. 1958. Coccoidioidomycosis and its treatment with amphotericin B in man Am. J. Med 24:568-592.
256. Littman, M. L. 1959. Cryptococcosis (torulosis). Am J. Med. 27:976.
257. Lokwood, W. R., F. Allison, B. E. Batson, and J. F. Busey. 1969. The treatment of North American blastomycosis. Am. Rev. Respir. Dis. 100: 314-320.
258. Lott, T. J., P. Boiron, and E. Reiss. 1987. An electrophoretic karyotype for Candida albicans reveals large chromosomes in multiples. Mol. Gen. Genet. 209:170-174.
259. Lott, T. J., L. S. Page, P. Boiron, J. Benson, and E. Reiss. 1989. The nucleotide sequence of the Candida albicans aspartyl proteinase gene. Nucleic Acids Res. 17:1779.
260. Lott, T. J., R. J. Kuykendall, S. F. Welbel, A. Pramanik, and B. A. Lasker. 1993. Genomic heterogeneity in the yeast Candida parapsilosis. Curr. Genet. 23:463-467.
261. Louria, D. B., N. Feder, and C. W. Emmons. 1956-1957. Amphotericin B in experimental histoplasmosis and cryptococcosis. Antibiot. Annu. 1956-1957:870-877.
262. Louria, D. B. 1958. Some aspects of the absorption, distribution, and excretion of amphotericin B in man Antibiot. Med. 5:295-301.
263. Louria, D. B., N. Fallon, and H. G. Browne. 1960. The influence of cortisone on experimental fungus infections in mice. J. Clin. Invest. 39:1435-1449.
264. Louria, D. B., and R. G. Brayton. 1964. Behavior of Candida cells within leukocytes. Proc. Soc. Exp. Biol. Med. 115:93-98.
265. Lupan, D. M., and J. Cazin, Jr. 1973. Pathogenicity of Alleschena boydii for mice. Infect. Immun. 8:743-751.
266. Lupan, D. M., and J. Cazin, Jr. 1976. Serological diagnosis of petiiellidiosis (allescheriosis). Mycopathologia 58:31-38
267. Lupan, D. M., and P. Nziramasanga. 1986. Collagenolytic activity of Coccidioides immitis. Infect. Immun. 51:360-361.
268. Lurie, H. I., and W. J. S. Still. 1969 The "capsule" of Sporotrichum schenckii and the evolution of the asteroid body: a light electron microscopic study. Sabouraudia 7:64-70.
269. Magee, B. B., and P. T. Magee. 1987. Electrophoretic karyotypes and chromosome numbers in Candida species. J. Gen. Microbiol. 133:425-430.
270. Magee, B. B., Y. Koltin, J. A. Gorman, and P. T. Magee. 1988 Assignment of cloned genes to the seven electrophoretically separated Candida albicans chromosomes. Mol. Cell. Biol. 8:4721-4726.
271. Magee, B. B., B. Hube, R. J. Wright, P. J. Sullivan, and P. T. Magee. 1993. The genes encoding the secreted aspartyl proteinases of Candida albicans constitute a family with at least three members. Infect. Immun 61:3240-3243.
272. Manning, M., and T. G. Mitchell. 1980. Morphogenesis of Candida albicans and cytoplasmic proteins associated with differences in morphology strain, or temperature J Bacteriol. 144:258-273.
273. Maresca, B., G. Medoff, D. Schlessinger, and G. S. Kobayashi. 1977 Regulation of dimorphism in the pathogenic fungus Histoplasma capsulatum. Nature (London) 266:447-448
274. Maresca, B., A. M. Lambowitz, V. B. Kumar, G. A. Grant, G. S. Kobayashi, and G. Medoff. 1981. Role of cysteine in regulating morphogenesis and mitochondrial activity in the dimorphic fungus Histoplasma capsulatum. Proc. Natl. Acad. Sci. USA 78:4596-4600.
275. Martin, D. S., R. D. Baker, and N. F. Conant. 1936. A case of verrucous dermatitis caused by Hormodendrum pedrosoi Am. J. Trop. Med. 16:593-619.
276. Mason, A. B., M. E. Brandt, and H. R. Buckley. 1989 Enolase activity associated with a C. albicans cytoplasmic antigen. Yeast 5:S231-S239.
277. Mason, M. M., B. A. Lasker, and W. S. Riggsby. 1937. Molecular probe for identification of medically important Candida species and Torulopsis glabrata. J Clin. Microbiol. 25:563-566.
278. McDnnough, E. S., and A. L. Lewis. 1967. Blastomyces dermatitidis: production of the sexual stage. Science 156:528-529.
279. McGinnis, M. R. 1977. Human pathogenic species of Exophiala, Phialophora and Wangiella. Proc. Fourth Int. Conf. Mycoses 356:37-59
280. McGinnis, M. R., and B. Katz. 1979. Ajellomyces and its synonym Emmonsiella. Mycotaxon 8:157-164.
281. McGinnis, M. R. 1983. Chiomoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J. Am Acad Dermatol. 8:1-16.
282. McGinnis, M. R., M. G. Rinaldi, and R. E. Winn. 1986. Emerging agents of phaeohyphomycosis, pathogenic species of Bipolaris and Exserohilum. J. Clin Microbiol. 24:250-259
283. McGinnis, M. R., D. Borelli, A. A. Padhye, and L. Ajello. 1986. Reclassification of Cladosporium bantianum in the genus Xylohypha. J Clin. Microbiol 23:1148-1151.
284. McGinnis, M. R. (University of Texas Medical Branch at Galveston). 1993. Personal communication.
285. McManus, J. F. A. 1948 A histological and histochemical uses of periodic acid. Stain Technol. 23:94-108.
286. Medlar, E. M. 1915. A cutaneous infection caused by a new fungus, Phialophora verrucosa, with a study of the fungus. J. Med. Res. 32:507-521.
287. Medoff, G., M. Comfort, and G. S. Kobayashi. 1971. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc. Soc. Exp. Biol Med. 138:571-574.
288. Medoff, G., G. S. Kobayashi, C. N. Kwan, D. Schlessinger, and P. Venkov. 1972 Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B. Proc. Natl. Acad. Sci USA 69:196-199.
289. Mendoza, L., S. M. Karuppayil, and P. J. Szaniszlo. 1993. Calcium regulates in vitro dimorphism in chromoblastomycotic fungi. Mycoses 36:157-164.
290. Merz, W. (Johns Hopkins Medical Institute at Baltimore). 1994. Personal communication
291. Meyer, R. D., L. S. Young, D. Armstrong, and G. Yu. 1973. Aspergillosis complicating neoplastic disease. Am. J. Med. 54:6-15
292. Meyer, W., T. G. Mitchell, E. Z. Freedman, and R. Vilgalys, 1993. Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans J. Clin. Microbiol. 31:2274-2280.
293. Miller, B. L., K. Y. Miller, and W. E. Timberlake. 1985. Direct and indirect gene replacement in Aspergillus nidulans. Mol. Cell. Biol. 5:1714-1721.
294. Miller, G. G., M. W. Witwer, A. L. Braude, and C. E. Davis. 1974. Rapid identification of Candida albicans septicemia in man by gas-liquid chroma-tography. J. Clin. Invest. 54:1235-1240
295. Mitchell, T. 1991. Need for training in medical mycology (training grant proposal). Duke University, Durham, N.C.
296. Monson, T. P., and K. P. Wilkinson. 1981. Mannose in body fluids as an indicator of invasive candidiasis. J. Clin. Microbiol. 14:557-562
297. Montgomery, F. H., and O. S. Ormsby. 1908. Systemic blastomycosis. Arch. Intern. Med. 2:1-41.
298. Moore, M., and L. V. Ackerman. 1946. Sporotrichosis with radiate formation in tissue. Arch Dermatol. Syphilol. 53:253-264.
299. Centers for Disease Control. 1981. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men, New York City and California. Morbid Mortal Weekly Rep. 30:305-308
300. Morrison, C., S. F. Hurst, S. L. Bragg, R. J. Kuykendall, H. Pohl, and E. Reiss. 1993. Heterogeneity of the purified extracellular asparty proteinase from Candida albicans: characterization with monoclonal antibodies and N-terminal amino acid sequence analysis. Infect. Immun. 61:2030-2036.
301. Morrow, B., T. Srikantha, and D. R. Soll. 1992. Transcription of the gene for a pepsinogen, PEP 1, is regulated by white-opaque switching in Candida albicans. Mol Cell. Biol. 12:2997-3005
302. Mosley, R. L., J. W. Murphy, and R. A. Cox. 1986. Immunoabsorption of Cryptococcus-specific suppression T-cell factors. Infect. Immun. 51:844-850.
303. Murphy, J. W., J. A. Gregory, and H. W. Larsh. 1974. Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect Immun 9:404-409
304. Murphy, J. W., and D. O. McDaniel. 1982. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. J. Immunol. 128:1577-1583
305. Murphy, J. W., R. L. Mosley, R. Cherniak, G. H. Reyes, T. R. Kozel, and E. Reiss. 1988 Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect. Immun. 56:424-431.
306. Murphy, J. W., M. R. Hidore, and S. C. Wong. 1993. Direct interactions of human lymphocytes with the yeast-like organism. Cryptococcus neoformans. J. Clin. Invest. 91:1553-1566.
307. Murphy, J. W. 1993. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect. Immun. 61:4750-4759
308. Nabavi, N, and J. W. Murphy. 1985. In vitro binding of natural killer cells to Cryptococcus neoformans targets. Infect Immun. 50:50-57.
309. Nakamura, L. T., B. A. Wu-Hsieh, and D. H. Howard. 1994. Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect Immun. 62: 680-684.
310. National Institute of Allergy and Infectious Diseases Mycoses Study Group. 1985. Treatment of blastomycosis and histoplasmosis with ketoconazole Ann. Intern. Med 103:861-782
311. Neill, J. M., J. Y. Sugg, and D. W. McCauley. 1951. Serologically reactive material in spinal fluid, blood, and urine from a human case of cryptococcosis (torulosis). Proc. Soc. Exp. Biol. Med 77:775-778.
312. Ness, M. J., W. P. Vaughan, and G. L. Woods. 1989. Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients. J Infect Dis. 159:495-502.
313. Newberry, W. M., J. W. Chandler, T. D. Chin, and C. H. Kirkpatrick. 1968. Immunology of the mycoses. I Depressed lymphocyte transformation in chronic histoplasmosis J. Immunol. 100:436-443.
314. Nichols, E. H. 1902 The relation of blastomycetes to cancer. J. Med. Res. 7:313-381.
315. Nickerson, W. J. 1953. Reduction of inorganic substances by yeasts. I. Extracellular reduction of sulfite by species of Candida. J. Infect. Dis. 93:43-56.
316. Nickerson, W. J., and Z. Mankowski. 1953. Role of nutrition in the maintenance of the yeast-shape in Candida. Am. J. Bot. 40:584-592.
317. Nickerson, W. J. 1954. An enzymatic locus participating in cellular division of a yeast. J. Gen. Physiol. 37:483-494.
318. Olaiya, A. F., and S. J. Sogin. 1979. Ploidy determination of Candida albicans J. Bacteriol. 140:1043-1049.
319. Ophüls, W., and H. C. Moffitt. 1900. A new pathogenic mould: preliminary report. Philadelphia Med. J. 5:1471-1472.
320. Ophüls, W. 1905. Further observations on a pathogenic mould formerly described as a protozoon (Coccidioides immitis, Coccidioides pyogenes). J. Exp. Med. 6:443-486.
321. Ouchterlony, O. 1949. Antigen-antibody reactions in gels. Acta Pathol. Microbiol. Scand. 26:507-515.
322. Oxford, A. E., H. Raistrick, and P. Simonart. 1939. Studies in the biochemistry of microorganisms. 60. Griseofulvin, a metabolic product of Penicillium griseofulvum Dicrek. Biochem. J. 33:240-248.
323. Palmer, C. E. 1945. Nontuberculous pulmonary calcification and sensitivity to histoplasmin. Public Health Rep (Washington) 60:513-520.
324. 320a Paltauf, A. 1885. Mycosis mucorina. ein Beitrag zur Kenntnis der menshlichen Fadenpilzer-Krankungen. Virchows Arch. Pathol. Anat. 102:543.
325. Pappagianis, D., R. L. Miller, C. E. Smith, and G. S. Kobayashi. 1960. Response of monkeys to respiratory challenge following subcutaneous inoculation with Coccidioides immitis. Am Rev. Respir Dis. 82:244-250.
326. Pappagianis, D., and the Valley Fever Vaccine Study Group. 1993. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am. Rev. Respir. Dis. 148:656-660.
327. Pappagianis, D. (University of California at Davis). 1993. Personal communication.
328. Pappas, P. G., M. G. Threlkeld, G. D. Bedsole, K. O. Cleveland, M. S. Gelfand, and W. E. Dismukes. 1993. Blastomycosis in immunocompromised patients. Medicine 72:311-325.
329. Perfect, J. R., B. B. Magee, and P. T. Magee. 1989. Separation of chromosomes of Cryptococcus neoformans by pulsed-field gel electrophoresis Infect. Immun. 57:2624-2627.
330. Perfect, J. (Duke University, Durham, N.C.). 1993. Personal communication.
331. Pfaller, M. A., M. G. Rinaldi, J. N. Galgiani, M. S. Bartlett, B. A. Body, A. Espinel-Ingroff, R. A. Fromtling, G. S. Hall, C. E. Hughes, F. C. Odds, and A. M. Sugar. 1990. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob. Agents Chemother. 34:1648-1654.
332. Pfaller, M. A., I. Cabezudo, B. Buschelman, M. Bale, T. Howe, M. Vitug, H. J. Linton, and M. Densel. 1993. Value of the hybritech ICON Candida assay in the diagnosis of invasive candidiasis in high-risk patients. Diagn. Microbiol. Infect. Dis. 16:53-60.
333. Pine, L., and C. L. Peacock. 1958. Studies on the growth of Histoplasma capsulatum. IV Factors influencing conversion of the mycelial phase to the yeast phase. J Bacteriol. 75:167-174.
334. Pine, L., and R. E. Webster. 1962. Conversion in strains of Histoplasma capsulatum. J Bacteriol. 83:149-157.
335. Powderly, W. G., M. S. Saag, G. A. Cloud, P. Robinson, R. D. Meyer, J. M. Jacobson, J. R. Graybill, A. M. Sugar, V. J. McAuliffe, S. E. Follansbee, C. U. Tuazon, J. J. Stern, J. Feinberg, R. Hafner, W. E. Dismukes, the National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group, and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. 1992. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N. Engl. J Med. 326:793-798.
336. Rappaport, B. Z., and B. Kaplan. 1926. Generalized Torula mycosis. Arch. Pathol. Lab Med. 1:720-741.
337. Reiss, E., S. H. Stone, and H. F. Hasenclever. 1974. Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls. Infect. Immun. 9:881-890.
338. Reiss, E., and P. F. Lehmann. 1979. The nature of the galoctomannan antigen of Aspergillus fumigatus Infect. Immun. 25:357-365.
339. Research Corporation. 1990. Gilbert Dalldorf and the Dalldorf Fellowship in Medical Mycology. Research Corporation, Tucson, Ariz.
340. Research Corporation. 1994. Two women scientists elected to the inventors hall of fame. Research Corporation, Tucson, Ariz.
341. Resnick, S., D. Pappagianis, and J. H. McKerrow. 1987. Proteinase production by the parasitic cycle of the pathogenic fungus Coccidioides immitis. Infect. Immun. 55:2807-2815
342. Rifkind, D., T. L. Marchioro, S. A. Schneck, and R. B. Hill. 1967 Systemicfungal infections complicating renal transplantation and immunosuppressive therapy. Am. J. Med. 43:28-38.
343. Riley, W. A., and C. J. Watson. 1926. Histoplasmosis of Darling with report of a case originating in Minnesota. Am. J. Trop. Med. 6:271-282.
344. Rinaldi, M. (University of Texas at San Antonio). 1994. Personal communication.
345. Rippon, J. W. 1967. Elastase: production by ringworm fungi. Science 157: 947
346. Rippon, J. W. 1968. Extracellular collagenase from Tnchophylon schoenleinii J. Bacteriol. 95:43-46.
347. Rippon, J. W., and E. D. Garber. 1969. Dermatophyte pathogenicity as a function of mating type and associated enzymes. J. Invest. Dermatol. 53: 445-448.
348. Rippon, J. W. (University of Chicago). 1994. Personal communication.
349. Rixford, E., and T. C. Gilchrist. 1896 Two cases of protozoan (coccidioidal) infection of the skin and other organs. Johns Hopkins Hosp. Rep. 1:209-268.
350. Robbins, W. J., and R. Ma. 1945. Growth factors for Trichophyton mentagrophytes. Am. J. Bot. 32:509-523
351. Roberts, G. D., C. Horstmeier, M. Hall, and J. A. Washington. 1975 Recovery of yeast from vented blood culture bottles. J. Clin. Microbiol. 2:18-20.
352. Roberts, G. D., H. S. Wang, and G. E. Holliek. 1976. Evaluation of the API 20C microtube system for the identification of clinically important yeasts. J. Clin. Microbiol 3:302-305.
353. Rockefeller Foundation. 1929. Unpublished award letter to Dr. Butler. Medical Mycological Society of the Americas Archives, Division of Infectious Diseases, Virginia Commonwealth University/MCV, Richmond.
354. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon Infect. Immun. 61:4870-4877.
355. Roilides, E., A. Holmes, C. Blake, P. A. Pizzo, and T. J. Walsh. 1993. Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J. Infect. Dis. 16:905-911.
356. Ruchel, R. 1981. Properties of a purified proteinase from the yeast Candida albicans Biochim Biophys Acta 659:99-113.
357. Saag, M. S., W. G. Powderly, G. A. Cloud, P. Robinson, M. H. Grieco, P. K. Sharkey, S. E. Thompson, A. M. Sugar, C. U. Tuazon, J. F. Fisher, N. Hyslop, J. M. Jacobson, R. Hafner, W. E. Dismukes, the National Institute of Allergy and Infectious Diseases Mycoses Study Group, and the AIDS Clinical Trials Group. 1992. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J Med. 326:83-89.
358. Saag, M. (University of Alabama at Birmingham). 1993. Personal communication.
359. 354a.Saag, M., C. Van Der Horst, G. Cloud, R. Hamill, R. Graybill, J. Sobel, P. Johnson, C. Tuazon, T. Kerkering, J. Fisher, H. Henderson, J. Stansell, D. Mildvan, L. Riser, D. Schneider, R. Hafner, C. Thomas, B. Weisinger, B. Moskovitz, and NIAID AIDS Clinical Trials Group and Mycoses Study Group. 1995. Randomized double blind comparison of amphotericin B plus flucytosine (AMB+PC) to AMB alone (step 1) followed by a comparison of fluconazole (FLU) to itraconazole (ITRA) (step 2) in the treatment of acute cryptococcal meningitis in patients with AIDS, abstr. 1217, p. 244. Abstr. 35th Intersci. Conf. Antimicrobiol. Agents Chemother. 1995. American Society for Microbiology, Washington, D.C.
360. 354b.Sabouraud, R. 1910. Les teignes (Lastineas). Masonet Cie, Paris.
361. Salkin, I. F. 1979. Further simplification of the Guizotia abyssinica seed medium for identification of Cryptococcus neoformans and Cryptococcus bacillispora. Can. J. Microbiol 25:1116-1118.
362. Salkin, I. F. (New York State Health Department, Albany). 1994. Personal communication
363. Salvin, S. B. 1949. Cysteine and related compounds in the growth of the yeast-like phase of Histoplasma capsulatum. J. Infect. Dis. 84:275-283.
364. Salvin, S. B. 1952. Endotoxin in pathogenic fungi. J. Immunol. 69:89-99.
365. Sarachek, A., D. D. Rhoads, and R. H. Schwarzhoff. 1981. Hybridization of Candida albicans through fusion of protoplasts Arch. Microbiol. 129:1-8.
366. Schaefer, J. C., B. Yu, and D. Armstrong. 1976. An Aspergillus immunodiffusion test in the early diagnosis of aspergillosis in adult leukemia patients Am. Rev. Respir. Dis. 113:325-329.
367. Schenck, B. R. 1898. On refractory subcutaneous abscesses caused by a fungus possibly related to the sporotricha. Johns Hopkins Hosp. Bull. 9:286-290.
368. Scherer, S., and R. W, Davis. 1979 Replacement of chromosome segments with altered DNA sequences constructed in vitro. Proc. Natl. Acad. Sci. USA 76:4951-4955.
369. Scherer, S., and D. A. Stevens. 1987. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J. Clin. Microbiol. 25:675-679.
370. Scherer, S., and D. A. Stevens. 1988 A Candida albicans dispersed repeated gene family and its epidemiology applications. Proc. Natl. Acad. Sci. USA 85:1452-1456.
371. Schoenbach, E. B., J. M. Miller, M. Ginsberg, and P. H. Long. 1951. Systemic blastomycosis treated with stilbamidine. JAMA 146:1317-1318
372. Schwartz, D. C., and C. R. Cantor. 1984 Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell 37:67-75.
373. Schwarz, J., and G. L. Baum. 1951. Blastomycosis. Am. J. Clin. Pathol. 21:999-1029.
374. Seabury, J. H., and H. E. Dascomb. 1958. Experience with amphotericin B for the treatment of systemic mycoses. Arch. Intern. Med 102:960-976.
375. Segal, E., R. A. Berg, P. A. Pizzo, and J. E. Bennett. 1979. Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J. Clin. Microbiol. 10:116-118.
376. Selsted, M. E., D. M. Brown, R. J. DeLange, S. L. Harwig, and R. I. Lehrer. 1985. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J. Biol. Chem 260:4579-4584.
377. Shadomy, H. J. 1970. Clamp connections in two strains of Cryptococcus neoformans. Spectrum Monogr. Ser. (Arts and Science, Georgia State University, Atlanta) 1:67-72.
378. Shadomy, H. J. (Medical College of Virginia). 1994. Personal communication.
379. Shadomy, S. 1969 In vitro studies with 5-fluorocytosine. Appl. Microbiol. 17:871-877.
380. Shaffer, M. F. 1985. History of medical mycology at Tulane Medical School. Unpublished manuscript, Tulane University, New Orleans, La.
381. Sharkey-Mathis, P. K., C. A. Kauffman, J. R. Graybill, D. A. Stevens, J. S. Hostetler, G. Cloud, W. E. Dismukes, and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. 1993. Treatment of sporotrichosis with itraconazole. Am J Med. 95:279-285.
382. Shear, C. L. 1922. Life history of an undescribed ascomycete isolated from a granular mycetoma of man. Mycologia 14:239-243.
383. Sidransky, H., and L. Friedman. 1959. The effect of cortisone and antibiotic agents on experimental pulmonary aspergillosis Am. J. Pathol. 35:169-183.
384. Silva, M., and R. W. Benham. 1952. Nutritional studies of the dermatophytes with special reference to Trichophyton megnini Blanchard 1896 and Trichophyton gallinae (Megnin 1881) comb. nov. J. Invest Dermatol 18: 453-472.
385. Silva, M., and R. W. Benham. 1954 Nutritional studies of the dermatophytes with special reference to the red-pigment producing-varieties of Trichophyton mentagrophytes. J. Invest. Dermatol. 22:285-294
386. Silva, M. E., and E. L. Hazen. 1957. Rhoda Williams Benham Mycologia 49:596-603.
387. Silva, M., B. M. Kesten, and R. W. Benham. 1955. Trichophyton rubrum infections, a clinical, mycologic, and experimental study J Invest. Dermatol. 25:311-328.
388. Silva-Hutner, M. E. 1975. Brief history of mycology laboratory, Columbia-Presbyterian Medical Center. Unpublished manuscript. Medical Mycological Society of the Americas Archives, Division of Infectious Diseases, Virginia Commonwealth University/MCV, Richmond.
389. Slutsky, B., J. Buffo, and D. R. Soll. 1985. High-frequency switching of colony morphology in Candida albicans. Science 230:666-669.
390. Smith, L. W., and M. E. Sano. 1933. Moniliasis with meningeal involvement. J. Infect. Dis. 53:187-196.
391. Smith, C. E. 1940. Epidemiology of acute coccidioidomycosis with erythema nodosum. Am. J. Public Health 30:600-611.
392. Smith, C. E., R. R. Beard, H. G. Rosenberger, and E. G. Whiting. 1946. Effect of season and dust control on coccidioidomycosis JAMA 132:833-838.
393. Smith, C. E., E. G. Whiting, E. E. Baker, H. G. Rosenberger, R. R. Beard, and M. T. Saito. 1948. The use of coccidioidin. Am. Rev. Tuberculosis 57:330-360.
394. Smith, C. E., M. T. Saito, R. R. Beard, R. M. Kepp, R. W. Clark, and B. U. Eddie. 1950. Serological tests in the diagnosis and prognosis of coccidioidomycosis. Am. J. Hyg. 52:1-21
395. Snapper, I., and L. V. McVay. 1953. The treatment of North American blastomycosis with 2-hydroxystilbamidine. Am. J. Med 15:603-623.
396. Sokol-Anderson, M. L., J. Brajtburg, and G. Medoff. 1986 Amphotericin B-induced oxidative damage and killing of Candida albicans. J. Infect. Dis. 154:76-83.
397. Soll, D. R., C. J. Langtimm, J. McDowell, J. Hicks, and R. Galask. 1987 High-frequency switching in Candida strains isolated from vaginitis patients. J. Clin. Microbiol. 25:1611-1622.
398. Southern, E. M. 1975 Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-518.
399. Spitzer, E. D., E. J. Keath, S. J. Travis, A. A, Painter, G. S. Kobayashi, and G. Medoff. 1990. Temperature-sensitive variants of Histoplasma capsulatum isolated from patients with acquired immunodeficiency syndrome. J. Infect. Dis. 162:258-261.
400. Spitzer, E. D., and S. G. Spitzer. 1992. Use of a dispersed repetitive DNA element to distinguish clinical isolates of Cryptococcus neoformans. J. Clin. Microbiol. 30:1094-1097b.
401. Srikantha, T., and D. R. Soll. 1993. A white specific gene in the white-opaque switching system of Candida albicans. Gene 131:53-60.
402. Staib, F. 1962. Cryptococcus neoformans und Guizotia abyssinica (syn G oleifera D.C.). Z. Hyg. Infektionskr. 148:456-475.
403. Staib, F. 1965. Serum-proteins as nitrogen source for yeast-like fungi. Sabouraudia 4:187-193.
404. Stamm, A, M., R. B. Diasio, W. E. Dismukes, S. Shadomy, G. A. Cloud, C. A. Bowles, G. M. Karam, A. Espinel-Ingroff, and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. 1987. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am. J. Med. 83:238-242.
405. Standard, P. G., and L. Kaufman. 1976. Specific immunological test for the rapid identification of members of the genus Histoplasma. J. Clin. Microbiol 3:191-199
406. Standard, P. G., and L. Kaufman. 1977. Immunological procedure for the rapid and specific identification of Coccidioides immitis cultures. J. Clin. Microbiol. 5:149-153.
407. Steinberg, B. A., W. P. Jambor, and L. O. Suydam. 1955-1956 Amphotericins A and B: two new antifungal antibiotics possessing high activity against deep-seated and superficial mycoses. Antibiot. Annu. 1955-1956:574-578.
408. Stenderup, A., and A. L. Bak. 1968. Deoxyribonucleic acid base composition of some species within the genus Candida. J. Gen. Microbiol. 52:231-236.
409. Stern, J. J., B. J. Hartman, P. Sharkey, V. Rowland, K. E. Squires, H. W. Murray, and J. R. Graybill. 1988 Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am. J. Med. 85:477-480.
410. Stevens, P., S. Huang, L. S. Young, and M. Berdischewsky. 1980. Detection of Candida antigenemia in human invasive candidiasis by a new solid phase radioimmunoassay. Infection 8:S334-S338
411. Stevens, D. A., S. I. Greene, and O. S. Lang. 1991. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Arch. Intern. Med. 151:2458-2464.
412. Stewart, R. A., and K. F. Meyer. 1932. Isolation of Coccidioides immitis (Stiles) from the soil. Proc. Soc. Exp. Biol. Med. 29:937-938.
413. Stockdale, P. M. 1963. The Microsporum gypseum complex (Nannizzia incurvata Stockd., N. gypsea (Nann.) comb. nov. N. fulva sp. nov.). Sabouraudia 3:114-126.
414. Stockman, L., K. A. Clark, J. M. Hunt, and G. D. Roberts. 1993. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis. Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum J. Clin. Microbiol. 31:845-850.
415. Stoddard, J. L., and E. C. Cutler. 1916. Torula infection in man. Rockefeller Inst. Med. Res. Monogr. 6:1-98
416. Storck, R. 1966 Nucleotide composition of nucleic acids of fungi. II. Deoxyribonuclcic acids. J. Bacteriol 91:227-230.
417. Sugar, A. M., and C. Saunders. 1988. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:481-489.
418. Sugar, A. M., and M. Picard. 1991 Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase implications for the pathogenesis of dimorphic fungal infections J. Infect. Dis. 163:371-375.
419. Sullivan, P. A., and R. J. Wright. 1992. Two genes for secreted aspartate proteinase in Candida albicans. Abstr 8th Int. Symp. Yeast, abstr. G-10, p. 203.
420. Swartz, J. H., and N. F. Conant. 1936. Direct microscopic examination of the skin: a method for the determination of the presence of fungi. Arch. Dermatol Syphilol 33:291-305.
421. Switchenko, A. C., C. G. Miyada, T. C. Goodman, J. J. Walsh, B. Wong, M. J. Becker, and E. F. Ullman. 1994. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J. Clin. Microbiol 32:92-97.
422. Syverson, R. E., H. R. Buckley, and C. C. Campbell. 1975. Cytoplasmic antigens unique to the mycclial or yeast phase of Candida albicans. Infect. Immun 12:1184-1188.
423. Szaniszlo, P. J., P. H. Hsieh, and J. D. Marlowe. 1976. Induction and ultrastructure of the multicellular (schlerotic) morphology in Phialophora dermatitidis Mycologia 48:117-130.
424. Taplin, D., N. Zaias, G. Rebell, and H. Blank. 1969. Isolation and recognition of dermatophytes on a new media (DTM). Arch. Dermatol. 99:203-209.
425. Tassel, D., and M. A. Madoff. 1968. Treatment of Candida sepsis and Cryprococcus meningitis with 5-fluorocytosine: a new antifungal agent. JAMA 206:830-832.
426. Titsworth, E., and E. Grunberg. 1973. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice Antimicrob. Agents Chemother 4:306-308.
427. Todd, R. L. 1937. Studies on yeast-like organisms isolated from the mouths and throats of normal persons. Am. J Hyg. 25:212-220.
428. Tompkins, L., J. J. Plorde, and S. Falkow. 1980 Molecular analysis of R-factors from multiresistant nosocomial isolates J. Infect. Dis. 141:625-636.
429. Torack, R. M. 1957 Fungus infections associated with antibiotic and steroid therapy. Am. J. Med. 22:872-882.
430. Utz, J. P., D. B. Louria, N. Feder, C. W. Emmons, and N. B. McCullough. 1957-1958. A report of clinical studies on the use of amphotericin in patients with systemic fungal diseases. Antibiot. Annu 1957-1958:65-70.
431. Utz, J. P., A. Treger, N. B. MeCullough, and C. W. Emmons. 1958-1959. Amphotericin B: intravenous use in 21 patients with systemic fungal diseases. Antibiot Annu. 1958-1959:628-634.
432. Utz, J. P., B. S. Tynes, H. J. Shadomy, R. J. Duma, M. M. Kannan, and K. N. Mason. 1969. 5-Fluorocytosine in human cryptococcosis, p. 344-349 Antimicrob. Agents Chcmother 1968
433. Utz, J. P., I. L. Garriques, M. A. Sande, J. F. Warner, G. L. Mandell, R. F. McGehee, R. J. Duma, and S. Shadomy. 1975 Therapy of cryptococcosis with combination of flucytosine and amphotericin B J. Infect. Dis 132: 368-373.
434. Utz, J. (Georgetown University Hospital, Washington, D.C.). 1994. Personal communication.
435. Van Pernis, P. A., M. E. Benson, and P. H. Holinger. 1941. Specific cutaneous reactions with histoplasmosis. JAMA 117:436-437.
436. Vasquez, J. A., A. Beckley, S. Donabedian, J. D. Sobel, and M. J. Zervos. 1993. Comparison of restriction enzyme analysis versus pulsed-field gradient electrophoresis as a typing system for Torulopsis glabrata and Candida species other than C. albicans. J. Clin Microbiol. 31:2021-2030.
437. Vogel, R. A., and J. F. Padula. 1958. Indirect staining reaction with fluorescent antibody for detection of antibodies to pathogenic fungi. Proc. Soc. Exp. Biol. Med. 98:135-139.
438. Vogel, R. A. 1966. The indirect fluorescent antibody test for the detection of antibody in human cryptococcal disease. J. Infect Dis 116:573-580
439. Vollrath, D., and R. W. Davis. 1987. Resolution of DNA molecules greater than 5 megabases by countour-clamped homogeneous electric fields. Nucleic Acids Res. 15:7865-7876.
440. Wadsworth, E., S. C. Prasad, and R. Calderone. 1993. Analysis of mannoproteins from blastoconidia and hyphae of Candida albicans with a common epitope recognized by anti-complement receptor type 2 antibodies Infect. Immun. 61:4675-4681
441. Waldorf, A. R., S. M. Levitz, and R. D. Diamond. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect Dis. 150:752-760.
442. Walker, J. W., and F. H. Montgomery. 1902. Further report of a previously recorded case of blastomycosis of the skin; systemic infection with blastomyces; death: autopsy. J. Am. Med. Assoc. 38:867-871.
443. Walsh, T. J., J. Lee, S. Aoki, F. Mechinaud, J. Bacher, J. Lecciones, V. Thomas, M. Rubin, and P. A. Pizzo. 1990. Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts, Rev. Infect. Dis. 12:S307-S317
444. Walsh, T. J., J. W. Hathorn, J. D. Sobel, W. G. Merz, V. Sanchez, S. M. Moret, H. R. Buckley, M. A. Pfaller, R. Schaufele, C. Sliva, E. Navarro, J. Lecciones, P. Chandrasekar, J. Lee, and P. A. Pizzo. 1991. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 324:1026-1031.
445. Walsh, T. J., W. G. Merz, J. W. Lee, H. Schaufele. T. Sein, P. O. Whitcomb, M. Ruddel, W. Burns, J. Wingard, A. C. Switchenko, T. Goodman, and P. A. Pizzo. 1995 Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol Am. J. Med. 99:164-172.
446. Weidman, F. D., and D. Spring. 1928. Comparison of ringworm culture ingredients: II and III. Arch Dermatol. Syphilol. 18:829-851
447. Weiner, M. H., and W. J. Yount. 1976. Mannan antigenemia in the diagnosis of invasive Candida infections. J Clin. Invest. 58:1045-1053
448. Weiner, M. H., and M. Coats-Stephen. 1979. Immunodiagnosis of systemic aspergillosis 1. Antigenemia detected by radioimniunoassay in experimental infections J Lab. Clin. Med. 93:111-119
449. Weiner, M. H. 1980. Antigenemia detected by radioimmunoassay in systemic aspergillosis Ann. Intern. Med. 92:793-796.
450. Weiner, M. H. 1983 Antigenemia detected in human coccidioidomycosis. J. Clin. Microbiol 18:136-142
451. Weitzman, I. 1964. incompatibility in the Microsporum gypseum complex Mycologia 56:425-435.
452. Weitzman, I. 1964. Variation in Microsporum gypseum. I. A genetic study of pleomorphism. Sabouraudia 3:195-204.
453. Weitzman, I., M. R. McGinnis, A. A. Padhye, and L. Ajello. 1986. The genus Arthroderma and its later synonym Nannizia. Mycotaxon 25:505-518.
454. Weitzman, I. (Columbia Presbyterian Medical Center, New York City). 1994 Personal communication.
455. Wheat, L. J., R. B. Kohler, and R. P. Tewari. 1986 Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N. Engl. J. Med. 314:83-88.
456. Wheat, L. J., P. Connolly-Stringfield, R. Blair, K. Connolly, T. Garringer, and B. P. Katz. 1991. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern. Med. 115:936-941.
457. Wheat, J., R. Hafner, M. Wulfsohn, P. Spencer, K. Squires, W. Powderly, B. Wong, M. Rinaldi, M. Saag, R. Hamill, R. Murphy, P. Connolly-Stringfield, N. Briggs, S. Owens, and the National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators. 1993. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern. Med. 118:610-616.
458. Whelan, W. L., R. M. Partridge, and P. T. Magee. 1980. Heterozygosity and segregation in Candida albicans. Mol. Gen. Genet. 180:107-113.
459. Whitaker, R. H. 1969 New concepts of kingdoms of organisms. Science 163:150-160.
460. White, C. J. 1899. Ringworm as it exists in Boston J. Cutaneous Genitourin. Dis. 17:1-17.
461. Wickerham, L. J., and K. A. Burton. 1948. Carbon assimilation tests for the classification of yeasts. J. Bacteriol. 56:363-371.
462. Wickes, B. L., J. E. Golin, and K. J. Kwon-Chung. 1991. Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype. Infect. Immun. 59:1762-1771.
463. Wickes, B., J. Staudinger, B. B. Magee, K. J. Kwon-Chung, P. T. Magee, and S. Scherer. 1991. Physical and genetic mapping of Candida albicans several genes previously assigned to chromosome 1 map to chromosome R. the rDNA-containing linkage group. Infect Immun. 59:2480-2484.
464. Williams, J. G. K., A. R. Kubelik, K. J. Livak, J. A. Rafalski, and S. V. Tingey. 1990. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 18:6531-6535
465. Wilson, J. W., C. E. Smith, and O. A. Plunkett 1953 Primary cutaneous coccidioidomycosis the criteria for diagnosis and a report of a case. Calif. Med. 79:233-239.
466. Wingard, J. R., W. G. Merz, and R. Saral. 1979 Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern. Med. 91:539-543.
467. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J Med. 325:1274-1277.
468. Winn, W. A. 1963. Coccidioidomycosis and amphotericin B Med Clin North Am. 47:1131-1148.
469. Wong, B., and K. L. Brauer. 1988. Enantioselective measurement of fungal D-arabinitol in the sera of normal adults and patients with candidiasis. J Clin. Microbiol. 26:1670-1674.
470. Wong, B., J. S. Murray, M. Castellanos, and K. D. Croen. 1993. D-Arabitol metabolism in Candida albicans. studies of the biosynthetic pathway and the gene that encodes NAD-dependent D-arabitol dehydrogenase. J. Bacteriol. 175:6314-6320.
471. Woods, J. P., D. Kersulyte, W. E. Goldman, and D. E. Berg. 1993 Fast DNA isolation from Histoplasma capsulatum: methodology for arbitrary-primer polymerase chain reaction-based epidemiological and clinical studies. J Clin Microbiol. 31:463-464.
472. Woolley, D. W. 1944. Some biological effects produced by benzimidazole and their reversal by purines. J. Biol. Chem. 152:225-232
473. Wright, J. H. 1898. A case of mycetoma (madura foot). J. Exp. Med 3:421-433.
474. Wu-Hsieh, B., and D. H. Howard. 1984. Inhibition of growth Histoplasma capsulatum by lymphokine-stimulated macrophages. J. Immunol 132:2593-2597.
475. Young, R. C-, J. E. Bennett, C. L. Vogel, P. P. Carbone, and V. T. DeVita. 1970. Aspergillosis: the spectrum of the disease in 98 patients. Medicine 49:147-173.
476. Yuan, L., and G. T. Cole. 1987. Isolation and characterization of an extracellular proteinase of Coccidioides immitis. Infect. Immun. 55:1970-1978
477. Zeidberg, L. D., L. Ajello, A. Dillon, and L. C. Runyon. 1952. Isolation of Histoplasma capsulatum from soil. Am. J Public Health 42:930-935.
478. Zimmerman, L. E. 1950. Candida and Aspergillus endocarditis. Arch Pathol 50:591-605.
479. Zimmerman, L. E., and H. Rappaport. 1954. Occurrence of cryptococcosis in patients with malignant disease of reticuloendothelial system. Am. J. Clin. Pathol. 24:1050-1072.